Cargo Therapeutics, a Bay Area biotech company, announced in a filing Tuesday that it is discontinuing its drug development ...

16:03 EDT Evaxion Biotech (EVAX) files $50M ordinary shares offering Easily identify stocks' risks and opportunities. Discover stocks' market position with detailed competitor analyses.

In a report released today, Gena Wang from Barclays maintained a Buy rating on Legend Biotech (LEGN – Research Report), with a price target of $94.00. The company’s shares closed yesterday at ...

MLB, Topps and Nike have partnered to recognize baseball's elite performers from last season with custom gold-embellished MLB logos on their jerseys that will then be used to create trading cards.

In a letter addressed to the San Diego Padres’ corporate partners and fans, Matt Seidler responded Tuesday to a lawsuit filed by his sister-in-law, Sheel Seidler, and emphasized that relocation ...

A recent study published in Advanced Functional Materials explores a novel method for functionalizing glass using ultrasonication of aryl diazonium salts. Earlier methods for glass functionalization, ...

The deal sees Lilly pay out $9 million upfront plus another $1 million after 15 months to the San Diego biotech, according to Securities and Exchange Commission (SEC) documents filed Feb. 25.

Better Tomorrow Ventures co-founder and general partner Sheel Mohnot says things most often slip through the cracks when he’s “super swamped.” “This is never about the founder and always ...

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

The year was 1975, before cell phones and email became ubiquitous, and Alex Capron remembers watching scientists lining up at a payphone during breaks at a conference. The payphone was in the main ...

About the VC: Founded in 2019 by NerdWallet co-founder Jake Gibson and Sheel Mohnot, Better Tomorrow Ventures leads rounds in pre-seed and seed-stage fintech companies globally. It has $225 ...

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...